Suggestions
Vishwas Seshadri
Head of Research and Clinical Development at Abeona Therapeutics
Professional Background
Vishwas Seshadri is a highly accomplished biopharmaceutical professional with over 10 years of diverse experience in the fields of commercialization and product development, particularly in the specialized areas of hematology and oncology. Currently, he serves as the Head of Research and Clinical Development at Abeona Therapeutics, a role that underscores his leadership and deep industry knowledge in advancing therapeutics for patients.
Previously, Vishwas held key leadership roles at notable companies, including Bristol Myers Squibb and Celgene (a Bristol Myers Squibb company), where he significantly contributed to product strategy and global marketing initiatives. As the Executive Director and worldwide brand lead for liso-cel (CAR-T), he drove the strategy and implementation of one of the most innovative therapies in oncology, showcasing his expertise in gene therapy and cellular treatment modalities. Vishwas's career trajectory reveals a strong progression through increasing levels of responsibility, reflecting his solid leadership qualities and dedication to improving patient outcomes through cutting-edge biopharmaceutical products.
His extensive experience at Celgene unmistakably positions him as a thought leader in the industry, having worked in a myriad of roles ranging from Senior Director of Global Marketing to Senior Product Manager in US Oncology Marketing. His deft combination of scientific knowledge and marketing acumen has empowered him to launch successful oncology products and reshaped market strategies worldwide.
Education and Achievements
Vishwas Seshadri’s educational background is impressive and reflects his commitment to understanding both the science and business of healthcare. He pursued an MBA with a focus on Healthcare and Finance at The Wharton School, further enhancing his strategic vision and financial acumen in the pharmaceutical landscape.
Prior to his MBA, Vishwas completed his doctorate in Microbiology and Immunology at the University of Arizona, where he engaged in vital research. This in-depth scientific training provided the foundation for his later work in biopharmaceuticals.
Additionally, he holds a Master's degree in Biotechnology from M.S. University in Baroda, which complements his scientific expertise with practical applications in biopharma. His undergraduate studies in Biochemistry at Delhi University further solidify his strong scientific foundation and understanding of biological sciences.
Vishwas's impressive educational qualifications, combined with his hands-on experience in leading research and clinical development teams, make him a valuable asset to any organization in the biopharmaceutical field.
Notable Achievements
Among his many achievements, Vishwas has been instrumental in numerous product launches that have greatly impacted the treatment of cancer patients. His strategic leadership in the global marketing of CAR-T therapies demonstrates his capability in not only scientific development but also in navigating the complexities of product commercialization on a worldwide scale. His ability to seamlessly blend science with marketing strategies has led to successful outcomes in various projects, given the ever-evolving dynamics of the biopharmaceutical landscape.
Throughout his career, Vishwas has consistently been recognized for his innovative approaches to commercialization and has successfully led cross-functional teams to achieve strategic goals. His experience in global business planning and marketing has enabled him to make significant contributions to the advancement of products that address unmet medical needs in oncology.
As a passionate advocate for improving patient access to innovative therapies, Vishwas continues to be a driving force in the biopharmaceutical industry, paving the way for future breakthroughs in cancer treatment and beyond.